Author:
Soman Gopalan,Yang Xiaoyi,Jiang Hengguang,Giardina Steve,Mitra Gautam
Funder
National Cancer Institute
National Institutes of Health
Subject
Immunology,Immunology and Allergy
Reference31 articles.
1. The ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro;Batova;Clin. Cancer Res.,1999
2. Treatment of high-risk neuroblastoma with anti-GD2 antibodies;Castel;Clin. Transl. Oncol.,2010
3. Utilization of ELISA technology to measure biological activities of carbohydrates relevant in disease status;Gervay;Curr. Med. Chem.,1999
4. High-level expression of chimeric antibodies using adapted cDNA variable region cassettes;Gillies;J. Immunol. Meth.,1989
5. Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group;Gilman;J. Clin. Oncol.,2009
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献